Curcumin and Chronic Kidney Disease (CKD): Major Mode of Action through Stimulating Endogenous Intestinal Alkaline Phosphatase
Tóm tắt
Curcumin, an active ingredient in the traditional herbal remedy and dietary spice turmeric (Curcuma longa), has significant anti-inflammatory properties. Chronic kidney disease (CKD), an inflammatory disease, can lead to end stage renal disease resulting in dialysis and transplant. Furthermore, it is frequently associated with other inflammatory disease such as diabetes and cardiovascular disorders. This review will focus on the clinically relevant inflammatory molecules that play a role in CKD and associated diseases. Various enzymes, transcription factors, growth factors modulate production and action of inflammatory molecules; curcumin can blunt the generation and action of these inflammatory molecules and ameliorate CKD as well as associated inflammatory disorders. Recent studies have shown that increased intestinal permeability results in the leakage of pro-inflammatory molecules (cytokines and lipopolysaccharides) from gut into the circulation in diseases such as CKD, diabetes and atherosclerosis. This change in intestinal permeability is due to decreased expression of tight junction proteins and intestinal alkaline phosphatase (IAP). Curcumin increases the expression of IAP and tight junction proteins and corrects gut permeability. This action reduces the levels of circulatory inflammatory biomolecules. This effect of curcumin on intestine can explain why, despite poor bioavailability, curcumin has potential anti-inflammatory effects in vivo and beneficial effects on CKD.
Từ khóa
Tài liệu tham khảo
Himmelfarb, 2002, The Elephant in Uremia: Oxidant Stress as a Unifying Concept of Cardiovascular Disease in Uremia, Kidney Int., 62, 1524, 10.1046/j.1523-1755.2002.00600.x
Moradi, 2013, Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease, Am. J. Nephrol., 38, 136, 10.1159/000351758
Lozano, 2012, Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2095, 10.1016/S0140-6736(12)61728-0
Jha, 2013, Chronic Kidney Disease: Global Dimension and Perspectives, Lancet, 382, 260, 10.1016/S0140-6736(13)60687-X
Singh, 2013, Metabolic Syndrome and Chronic Kidney Disease, Curr. Opin. Nephrol. Hypertens., 22, 198, 10.1097/MNH.0b013e32835dda78
Gupta, 2013, Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials, AAPS J., 15, 195, 10.1208/s12248-012-9432-8
Hatcher, 2008, Curcumin: From Ancient Medicine to Current Clinical Trials, Cell. Mol. Life Sci., 65, 1631, 10.1007/s00018-008-7452-4
Aggarwal, 2010, Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals, Annu. Rev. Nutr., 30, 173, 10.1146/annurev.nutr.012809.104755
Aggarwal, 2009, Pharmacological Basis for the Role of Curcumin in Chronic Diseases: An Age-Old Spice with Modern Targets, Trends Pharmacol. Sci., 30, 85, 10.1016/j.tips.2008.11.002
Prasad, 2014, Curcumin, a Component of Golden Spice: From Bedside to Bench and Back, Biotechnol. Adv., 32, 1053, 10.1016/j.biotechadv.2014.04.004
Shishodia, 2013, Molecular Mechanisms of Curcumin Action: Gene Expression, Biofactors, 39, 37, 10.1002/biof.1041
Rios, 2012, Cyclooxygenase-2 and Kidney Failure, Prostaglandins Other Lipid Mediat., 98, 86, 10.1016/j.prostaglandins.2011.11.004
Horiba, 2002, Subtotal Nephrectomy Stimulates Cyclooxygenase 2 Expression and Prostacyclin Synthesis in the Rat Remnant Kidney, Nephron, 91, 134, 10.1159/000057615
Ghosh, 2012, Curcumin and Enalapril Ameliorate Renal Failure by Antagonizing Inflammation in 5/6 Nephrectomized Rats: Role of Phospholipase and Cyclooxygenase, Am. J. Physiol. Ren. Physiol., 302, F439, 10.1152/ajprenal.00356.2010
Maccarrone, 2003, 5-Lipoxygenase-Mediated Mitochondrial Damage and Apoptosis of Mononuclear Cells in ESRD Patients, Kidney Int., 63, S33, 10.1046/j.1523-1755.63.s84.26.x
Radmark, 2007, 5-Lipoxygenase: Regulation and Possible Involvement in Atherosclerosis, Prostaglandins Other Lipid Mediat., 83, 162, 10.1016/j.prostaglandins.2007.01.003
Stenvinkel, 2001, Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient, Blood Purif., 19, 53, 10.1159/000014479
Stenvinkel, 2005, IL-10, IL-6, and TNF-Alpha: Central Factors in the Altered Cytokine Network of Uremia—The Good, the Bad, and the Ugly, Kidney Int., 67, 1216, 10.1111/j.1523-1755.2005.00200.x
Fink, 2012, Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline, Ann. Intern. Med., 156, 570, 10.7326/0003-4819-156-8-201204170-00008
Shing, 2011, Nutritional Compounds Influence Tissue Factor Expression and Inflammation of Chronic Kidney Disease Patients in Vitro, Nutrition, 27, 967, 10.1016/j.nut.2010.10.014
Moreillon, 2013, The use of an Anti-Inflammatory Supplement in Patients with Chronic Kidney Disease, J. Complement. Integr. Med., 10, 1, 10.1515/jcim-2012-0011
Choi, 2014, Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease, Molecules, 19, 12727, 10.3390/molecules190812727
Soetikno, 2011, Curcumin Attenuates Diabetic Nephropathy by Inhibiting PKC-Alpha and PKC-beta1 Activity in Streptozotocin-Induced Type I Diabetic Rats, Mol. Nutr. Food Res., 55, 1655, 10.1002/mnfr.201100080
Tapia, 2008, Effect of Febuxostat on the Progression of Renal Disease in 5/6 Nephrectomy Rats with and without Hyperuricemia, Nephron Physiol., 108, p69, 10.1159/000127837
Ghosh, 2008, Role of Pla2 and Arachidonic Acid Metabolism in Inflammation during Renal Failure, J. Am. Soc. Nephrol., 19, 852
Small, 2012, Oxidative Stress, Anti-Oxidant Therapies and Chronic Kidney Disease, Nephrology, 17, 311, 10.1111/j.1440-1797.2012.01572.x
Cybulsky, 2000, Growth Factor Pathways in Proliferative Glomerulonephritis, Curr. Opin. Nephrol. Hypertens., 9, 217, 10.1097/00041552-200005000-00003
2012, Role of TGF-Beta in Chronic Kidney Disease: An Integration of Tubular, Glomerular and Vascular Effects, Cell Tissue Res., 347, 141, 10.1007/s00441-011-1275-6
Khajehdehi, 2011, Oral Supplementation of Turmeric Attenuates Proteinuria, Transforming Growth Factor-Beta and Interleukin-8 Levels in Patients with Overt Type 2 Diabetic Nephropathy: A Randomized, Double-Blind and Placebo-Controlled Study, Scand. J. Urol. Nephrol., 45, 365, 10.3109/00365599.2011.585622
Ghosh, 2003, PPARgamma Ligand Attenuates PDGF-Induced Mesangial Cell Proliferation: Role of MAP Kinase, Kidney Int., 64, 52, 10.1046/j.1523-1755.2003.00054.x
Nakagawa, 2013, Uncoupling of VEGF with Endothelial NO as a Potential Mechanism for Abnormal Angiogenesis in the Diabetic Nephropathy, J. Diabetes Res., 2013, 184539, 10.1155/2013/184539
Zhang, 2014, Curcumin Attenuates Angiogenesis in Liver Fibrosis and Inhibits Angiogenic Properties of Hepatic Stellate Cells, J. Cell. Mol. Med., 18, 1392, 10.1111/jcmm.12286
Ghosh, 2010, Curcumin Prevents Cardiac Remodeling Secondary to Chronic Renal Failure through Deactivation of Hypertrophic Signaling in Rats, Am. J. Physiol. Heart Circ. Physiol., 299, H975, 10.1152/ajpheart.00154.2010
Ye, 2008, Regulation of PPARgamma Function by TNF-Alpha, Biochem. Biophys. Res. Commun., 374, 405, 10.1016/j.bbrc.2008.07.068
Ghosh, 2009, Curcumin Ameliorates Renal Failure in 5/6 Nephrectomized Rats: The Role of Inflammation, Am. J. Physiol. Ren. Physiol., 296, 1146, 10.1152/ajprenal.90732.2008
Uwe, 2008, Anti-Inflammatory Interventions of NF-kappaB Signaling: Potential Applications and Risks, Biochem. Pharmacol., 75, 1567, 10.1016/j.bcp.2007.10.027
Oeckinghaus, 2011, Crosstalk in NF-kappaB Signaling Pathways, Nat. Immunol., 12, 695, 10.1038/ni.2065
Guijarro, 2001, Transcription Factor-Kappa B (NF-Kappa B) and Renal Disease, Kidney Int., 59, 415, 10.1046/j.1523-1755.2001.059002415.x
Pedruzzi, 2012, Nrf2-keap1 System Versus NF-kappaB: The Good and the Evil in Chronic Kidney Disease?, Biochimie, 94, 2461, 10.1016/j.biochi.2012.07.015
Fujihara, 2007, Chronic Inhibition of Nuclear Factor-kappaB Attenuates Renal Injury in the 5/6 Renal Ablation Model, Am. J. Physiol. Ren. Physiol., 292, F92, 10.1152/ajprenal.00184.2006
Zoja, C., Benigni, A., and Remuzzi, G. (2014). The Nrf2 Pathway in the Progression of Renal Disease. Nephrol. Dial. Transplant.
Kim, 2010, Contribution of Impaired Nrf2-Keap1 Pathway to Oxidative Stress and Inflammation in Chronic Renal Failure, Am. J. Physiol. Renal Physiol., 298, F662, 10.1152/ajprenal.00421.2009
Zoja, C., Abbate, M., and Remuzzi, G. (2014). Progression of Renal Injury toward Interstitial Inflammation and Glomerular Sclerosis is Dependent on Abnormal Protein Filtration. Nephrol. Dial. Transplant.
Massiah, 2001, Potency of Michael Reaction Acceptors as Inducers of Enzymes that Protect Against Carcinogenesis Depends on their Reactivity with Sulfhydryl Groups, Proc. Natl. Acad. Sci. USA, 98, 3404, 10.1073/pnas.051632198
Talalay, 1999, Relation of Structure of Curcumin Analogs to their Potencies as Inducers of Phase 2 Detoxification Enzymes, Carcinogenesis, 20, 911, 10.1093/carcin/20.5.911
Soetikno, 2013, Curcumin Alleviates Oxidative Stress, Inflammation, and Renal Fibrosis in Remnant Kidney through the Nrf2-keap1 Pathway, Mol. Nutr. Food Res., 57, 1649, 10.1002/mnfr.201200540
Kon, 2011, Atherosclerosis in Chronic Kidney Disease: The Role of Macrophages, Nat. Rev. Nephrol., 7, 45, 10.1038/nrneph.2010.157
Jacob, 2013, Curcumin Alleviates Immune-Complex-Mediated Glomerulonephritis in Factor-H-Deficient Mice, Immunology, 139, 328, 10.1111/imm.12079
Cohen, 2012, Hypertension and Kidney Disease: What do the Data really show?, Curr. Hypertens. Rep., 14, 462, 10.1007/s11906-012-0285-4
Garimella, 2013, Current Issues in the Management and Monitoring of Hypertension in Chronic Kidney Disease, Curr. Opin. Nephrol. Hypertens., 22, 599, 10.1097/MNH.0b013e328365addf
Tapia, E., Soto, V., Ortiz-Vega, K.M., Zarco-Marquez, G., Molina-Jijon, E., Cristobal-Garcia, M., Santamaria, J., Garcia-Nino, W.R., Correa, F., and Zazueta, C. (2012). Curcumin Induces Nrf2 Nuclear Translocation and Prevents Glomerular Hypertension, Hyperfiltration, Oxidant Stress, and the Decrease in Antioxidant Enzymes in 5/6 Nephrectomized Rats. Oxidative Med. Cell. Longev., 2012.
Tapia, 2013, Curcumin Reverses Glomerular Hemodynamic Alterations and Oxidant Stress in 5/6 Nephrectomized Rats, Phytomedicine, 20, 359, 10.1016/j.phymed.2012.11.014
Abbate, 2006, How does Proteinuria Cause Progressive Renal Damage?, J. Am. Soc. Nephrol., 17, 2974, 10.1681/ASN.2006040377
Khajehdehi, 2012, Oral Supplementation of Turmeric Decreases Proteinuria, Hematuria, and Systolic Blood Pressure in Patients Suffering from Relapsing Or Refractory Lupus Nephritis: A Randomized and Placebo-Controlled Study, J. Ren. Nutr., 22, 50, 10.1053/j.jrn.2011.03.002
Vanholder, 2008, European Uremic Toxin Work Group. A Bench to Bedside View of Uremic Toxins, J. Am. Soc. Nephrol., 19, 863, 10.1681/ASN.2007121377
Vanholder, 2003, European Uremic Toxin Work Group. New Insights in Uremic Toxins, Kidney Int., 84, S6, 10.1046/j.1523-1755.63.s84.43.x
Duranton, 2012, Normal and Pathologic Concentrations of Uremic Toxins, J. Am. Soc. Nephrol., 23, 1258, 10.1681/ASN.2011121175
Miyagi, 2010, Impact of Renal Function on Coronary Plaque Composition, Nephrol. Dial. Transplant., 25, 175, 10.1093/ndt/gfp423
Pelisek, 2011, Impact of Chronic Kidney Disease on Carotid Plaque Vulnerability, J. Vasc. Surg., 54, 1643, 10.1016/j.jvs.2011.05.049
Tousoulis, 2014, Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease: The Emerging Role of Statins, J. Am. Coll. Cardiol., 63, 2491, 10.1016/j.jacc.2014.01.054
Shin, 2011, Long-Term Curcumin Administration Protects Against Atherosclerosis Via Hepatic Regulation of Lipoprotein Cholesterol Metabolism, Mol. Nutr. Food Res., 55, 1829, 10.1002/mnfr.201100440
Liu, 2014, Curcumin Inhibits Monocyte Chemoattractant Protein-1 Expression and Enhances Cholesterol Efflux by Suppressing the c-Jun N-Terminal Kinase Pathway in Macrophage, Inflamm. Res., 63, 841, 10.1007/s00011-014-0758-9
Hasan, 2014, Curcumin Modulation of High Fat Diet-Induced Atherosclerosis and Steatohepatosis in LDL Receptor Deficient Mice, Atherosclerosis, 232, 40, 10.1016/j.atherosclerosis.2013.10.016
Ghosh, 2014, Oral Supplementation with Non-Absorbable Antibiotics Or Curcumin Attenuates Western Diet-Induced Atherosclerosis and Glucose Intolerance in LDLR-/- Mice—Role of Intestinal Permeability and Macrophage Activation, PLoS One, 9, e108577, 10.1371/journal.pone.0108577
Morimoto, 2008, The Dietary Compound Curcumin Inhibits p300 Histone Acetyltransferase Activity and Prevents Heart Failure in Rats, J. Clin. Investig., 118, 868
Cruz, 2013, Pathophysiology of Cardiorenal Syndrome Type 2 in Stable Chronic Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI), Contrib. Nephrol., 182, 117, 10.1159/000349968
Gullestad, 2005, Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches, Am. J. Cardiol., 95, 17, 10.1016/j.amjcard.2005.03.008
Sarafidis, 2006, Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications, Am. J. Nephrol., 26, 232, 10.1159/000093632
Sun, 2009, Endotoxin-Binding Affinity of Sevelamer: A Potential Novel Anti-Inflammatory Mechanism, Kidney Int., 76, S20, 10.1038/ki.2009.403
Vaziri, 2012, Disintegration of Colonic Epithelial Tight Junction in Uremia: A Likely Cause of CKD-Associated Inflammation, Nephrol. Dial. Transplant., 27, 2686, 10.1093/ndt/gfr624
Anders, 2013, The Intestinal Microbiota, a Leaky Gut, and Abnormal Immunity in Kidney Disease, Kidney Int., 83, 1010, 10.1038/ki.2012.440
Anand, 2007, Bioavailability of Curcumin: Problems and Promises, Mol. Pharm., 4, 807, 10.1021/mp700113r
Sharma, 2007, Pharmacokinetics and Pharmacodynamics of Curcumin, Adv. Exp. Med. Biol., 595, 453, 10.1007/978-0-387-46401-5_20
Hoyer, 1993, Clinical Pharmacokinetics of Angiotensin Converting Enzyme (ACE) Inhibitors in Renal Failure, Clin. Pharmacokinet., 24, 230, 10.2165/00003088-199324030-00005
Schachter, 2005, Chemical, Pharmacokinetic and Pharmacodynamic Properties of Statins: An Update, Fundam. Clin. Pharmacol., 19, 117, 10.1111/j.1472-8206.2004.00299.x
Ramezani, 2014, The Gut Microbiome, Kidney Disease, and Targeted Interventions, J. Am. Soc. Nephrol., 25, 657, 10.1681/ASN.2013080905
Vaziri, 2013, Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction, Am. J. Nephrol., 38, 99, 10.1159/000353764
Vaziri, 2012, CKD Impairs Barrier Function and Alters Microbial Flora of the Intestine: A Major Link to Inflammation and Uremic Toxicity, Curr. Opin. Nephrol. Hypertens., 21, 587, 10.1097/MNH.0b013e328358c8d5
Carvalho, 2012, Modulation of Gut Microbiota by Antibiotics Improves Insulin Signalling in High-Fat Fed Mice, Diabetologia, 55, 2823, 10.1007/s00125-012-2648-4
Adesso, 2013, The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS, PLoS One, 8, e76778, 10.1371/journal.pone.0076778
Huang, 2008, Curcumin Inhibits the Increase of Glutamate, Hydroxyl Radicals and PGE2 in the Hypothalamus and Reduces Fever during LPS-Induced Systemic Inflammation in Rabbits, Eur. J. Pharmacol., 593, 105, 10.1016/j.ejphar.2008.07.017
Charalambous, 2007, Role of Bacterial Endotoxin in Chronic Heart Failure: The Gut of the Matter, Shock, 28, 15, 10.1097/shk.0b013e318033ebc5
Edelblum, 2009, The Tight Junction in Inflammatory Disease: Communication Breakdown, Curr. Opin. Pharmacol., 9, 715, 10.1016/j.coph.2009.06.022
Bentala, 2002, Removal of Phosphate from Lipid A as a Strategy to Detoxify Lipopolysaccharide, Shock, 18, 561, 10.1097/00024382-200212000-00013
Lalles, 2014, Intestinal Alkaline Phosphatase: Novel Functions and Protective Effects, Nutr. Rev., 72, 82, 10.1111/nure.12082
Wang, 2009, Study on the Antibiotic Activity of Microcapsule Curcumin against Foodborne Pathogens, Int. J. Food Microbiol., 136, 71, 10.1016/j.ijfoodmicro.2009.09.001
Prasad, 2014, Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: The Golden Pigment from Golden Spice, Cancer. Res. Treat., 46, 2, 10.4143/crt.2014.46.1.2
Zhongfa, 2012, Enhancement of Curcumin Oral Absorption and Pharmacokinetics of Curcuminoids and Curcumin Metabolites in Mice, Cancer Chemother. Pharmacol., 69, 679, 10.1007/s00280-011-1749-y